The article examines the structure and implications of supplementary protection certificates in the European Union. It reviews their regulatory evolution, procedural requirements, and influence on pharmaceutical market exclusivity, while also considering comparative perspectives from India.
Read more about Revisiting Supplementary Protection Certificates of the European Union